YU31496A - Asimetrična sinteza (-)6-hlor-4-ciklopropiletinil-4-trifluorometil-1,4-dihidro-2h-3,1-benzoksazin-2-ona - Google Patents

Asimetrična sinteza (-)6-hlor-4-ciklopropiletinil-4-trifluorometil-1,4-dihidro-2h-3,1-benzoksazin-2-ona

Info

Publication number
YU31496A
YU31496A YU31496A YU31496A YU31496A YU 31496 A YU31496 A YU 31496A YU 31496 A YU31496 A YU 31496A YU 31496 A YU31496 A YU 31496A YU 31496 A YU31496 A YU 31496A
Authority
YU
Yugoslavia
Prior art keywords
trifluoromethyl
cyclopropylethynyl
benzoxazin
dihydro
chloro
Prior art date
Application number
YU31496A
Other languages
English (en)
Other versions
YU48940B (sh
Inventor
Andrew Thompson
Edward Corley
Edward Grabowski
Nobuyoshi Yasuda
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU31496A publication Critical patent/YU31496A/sh
Publication of YU48940B publication Critical patent/YU48940B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/70—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Opisana je sinteza veoma jakog inhibitora HIV reverzne transkriptaze, koja obuhvata acetilid i trifluorometil keton, koja proizvodi hiralni proizvod u prisustvu hiralnog amino alkohola.
YU31496A 1995-05-25 1996-05-24 Asimetrična sinteza (-)6-hlor-4-ciklopropiletinil-4-trifluorometil-1,4-dihidro-2h-3,1-benzoksazin-2-ona YU48940B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/450,330 US5633405A (en) 1995-05-25 1995-05-25 Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one

Publications (2)

Publication Number Publication Date
YU31496A true YU31496A (sh) 1998-11-05
YU48940B YU48940B (sh) 2002-12-10

Family

ID=23787667

Family Applications (1)

Application Number Title Priority Date Filing Date
YU31496A YU48940B (sh) 1995-05-25 1996-05-24 Asimetrična sinteza (-)6-hlor-4-ciklopropiletinil-4-trifluorometil-1,4-dihidro-2h-3,1-benzoksazin-2-ona

Country Status (26)

Country Link
US (2) US5633405A (sh)
EP (1) EP0828703B1 (sh)
JP (1) JP2839717B2 (sh)
KR (1) KR100399511B1 (sh)
CN (1) CN1119319C (sh)
AR (1) AR002997A1 (sh)
AT (1) ATE196463T1 (sh)
AU (1) AU709273B2 (sh)
BR (1) BR9608839A (sh)
CA (1) CA2220389C (sh)
CZ (1) CZ292848B6 (sh)
DE (1) DE69610422T2 (sh)
DK (1) DK0828703T3 (sh)
EA (1) EA000107B1 (sh)
ES (1) ES2151666T3 (sh)
GR (1) GR3034897T3 (sh)
HR (1) HRP960233B1 (sh)
HU (1) HU223565B1 (sh)
MX (1) MX199501B (sh)
NZ (1) NZ308824A (sh)
PT (1) PT828703E (sh)
SK (1) SK282412B6 (sh)
TW (1) TW402581B (sh)
UA (1) UA56137C2 (sh)
WO (1) WO1996037457A1 (sh)
YU (1) YU48940B (sh)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2260922A1 (en) * 1996-07-26 1998-02-05 Du Pont Pharmaceuticals Company A practical synthesis of benzoxazinones useful as hiv reverse transcriptase inhibitors
US5874430A (en) 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US5932726A (en) * 1996-12-16 1999-08-03 Dupont Pharmaceuticals Company Asymmetric synthesis of benzoxazinones
AU5521498A (en) * 1996-12-16 1998-07-15 Du Pont Pharmaceuticals Company An improved synthesis of cyclopropylacetylene
EP0973737A4 (en) * 1997-01-10 2000-04-26 Merck & Co Inc EFFECTIVE SYNTHESIS OF A CHIRAL MEDIATOR
US5965729A (en) * 1997-02-05 1999-10-12 Merck & Co., Inc. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
CN1191242C (zh) * 1997-02-05 2005-03-02 麦克公司 不同结晶型的(－)－6－氯－4－环丙乙炔基－4－三氟甲基－1,4－二氢－2h－3,1－苯并噁嗪－2－酮
AU760075B2 (en) * 1997-02-05 2003-05-08 Merck Sharp & Dohme Corp. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
US5922864A (en) * 1997-02-12 1999-07-13 Merck & Co., Inc. Efficient synthesis of a 1,4-dihydro2H-3,1-benzoxazin-2-one
TW480253B (en) * 1997-02-12 2002-03-21 Merck & Co Inc Efficient synthesis of a 1,4-dihydro-2H-3,1-benzoxazin-2-one
JP2001519810A (ja) * 1997-04-07 2001-10-23 デュポン ファーマシューティカルズ カンパニー 新規中間体を経由するベンゾオキサジノン類の不斉合成
AR011731A1 (es) * 1997-05-16 2000-08-30 Merck & Co Inc Un proceso de reaccion de adicion enantioselectiva eficiente utilizando un reactivo de organozinc.
US6072094A (en) * 1997-08-06 2000-06-06 Merck & Co., Inc. Efficient synthesis of cyclopropylacetylene
JP2001513518A (ja) * 1997-08-06 2001-09-04 メルク エンド カムパニー インコーポレーテッド シクロプロピルアセチレンの効率的な合成
WO1999048848A1 (en) * 1998-03-24 1999-09-30 Great Lakes Chemical Corporation Method to reduce the amount of phosphorus oxyhalides and dihalogenated pentenes in 1,1-dihalo-1-cyclopropylethanes
EP1332757B1 (en) * 1998-05-27 2012-06-13 Merck Sharp & Dohme Corp. Efavirenz compressed tablet formulation
US20010014352A1 (en) 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
CO5070643A1 (es) * 1998-05-27 2001-08-28 Merck & Co Inc Formulacion en tabletas comprimidas
US6673372B1 (en) 1998-06-11 2004-01-06 Bristol-Myers Squibb Pharma Company Crystalline Efavirenz
HRP990182A2 (en) * 1998-06-11 2000-02-29 Du Pont Pharm Co Crystalline efavirenz
US6235957B1 (en) 1998-06-29 2001-05-22 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
US6288297B1 (en) 1998-10-01 2001-09-11 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
WO2000018706A1 (en) 1998-10-01 2000-04-06 Du Pont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
GB2355988A (en) 1999-10-28 2001-05-09 Merck & Co Inc Synthesis of cyclopropylacetylene in a one-pot process using a diazo-keto-phos phonate
GB2355724A (en) 1999-10-28 2001-05-02 Merck & Co Inc Synthesis of cyclopropylacetylene from propiolic acid (2-propynoic acid)
CN1331601C (zh) * 2003-05-16 2007-08-15 中国科学院上海有机化学研究所 手性氨基醇配体应用于端炔对含氟烷基芳基酮的不对称加成的方法
US7439400B2 (en) 2003-04-04 2008-10-21 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Amino alcohol ligand and its use in preparation of chiral proparglic tertiary alcohols and tertiary amines via enantioselective addition reaction
US7271252B2 (en) 2003-04-22 2007-09-18 Roche Diagnostics Operations, Inc. Reagents for detecting efavirenz
US7420043B2 (en) * 2003-12-10 2008-09-02 Roche Diagnostics Operations, Inc. Reagents for detecting efavirenz
US9073817B2 (en) 2008-01-31 2015-07-07 Laurus Labs Private Limited Efficient process to induce enantioselectivity in procarbonyl compounds
ZA200806473B (en) * 2008-01-31 2009-04-29 Aptuit Laurus Pvt Ltd An efficient process to induce enantioselectivity in procarbonyl compounds
EP2313379B1 (en) 2008-05-30 2015-03-11 Emcure Pharmaceuticals Limited Process for the preparation of efavirenz
EP2417097A2 (en) 2009-04-09 2012-02-15 Lonza Ltd. Autocatalytic process for the synthesis of chiral propargylic alcohols
EP2417096B1 (en) 2009-04-09 2013-01-16 Lonza Ltd. Process for the synthesis of a propargylic alcohol
WO2011000532A2 (de) 2009-07-03 2011-01-06 Archimica Gmbh Verfahren zur enantioselektiven addition von organometallischen kohlenstoffnukleophilen an trifluormethylketone und verwendung des verfahrens in der synthese von hiv reverse transcriptase inhibitoren
CN101844990B (zh) * 2010-05-27 2013-03-20 浙江沙星医药化工有限公司 中间体4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的合成方法
EP2447247A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of chiral propargylic alcohols
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2471783A1 (en) 2010-12-23 2012-07-04 Esteve Química, S.A. Novel polymorphic form of efavirenz
CN102617370B (zh) * 2012-03-05 2014-06-04 浙江江北药业有限公司 (S)-5-氯-α-(环丙乙炔基)-2-(((4-甲氧基苯基)甲基)氨基)-α-(三氟甲基)苯甲醇的制备方法
WO2015118515A1 (en) * 2014-02-10 2015-08-13 Discovery Intermediates Private Limited An improved process for the preparation of a non-nucleoside reverse transcriptase inhibitor
CN104016936B (zh) * 2014-06-18 2016-08-17 中国科学院上海有机化学研究所 手性氨基酚配体在依法韦仑不对称合成中的应用
DE202015104551U1 (de) 2015-08-27 2015-12-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Reaktoren für die Herstellung von Efavirenz sowie Zwischenprodukte
US9676735B2 (en) 2015-08-27 2017-06-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Process for the preparation of efavirenz and devices suitable therefore
CN105801442A (zh) * 2015-10-16 2016-07-27 浙江沙星医药化工有限公司 4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的制备方法
JP7071036B2 (ja) 2019-02-15 2022-05-18 福建永晶科技股▲ふん▼有限公司 Ｆｒｉｅｄｅｌ－Ｃｒａｆｔｓ反応の新しい新方法及び当該方法に用いられる触媒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55145625A (en) * 1979-05-01 1980-11-13 Mitsubishi Chem Ind Ltd Preparation of alkynyl alcohol
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
US5663169A (en) * 1992-08-07 1997-09-02 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type

Also Published As

Publication number Publication date
MX199501B (es) 2000-11-10
ES2151666T3 (es) 2001-01-01
CZ370997A3 (cs) 1998-04-15
AU5866796A (en) 1996-12-11
DE69610422D1 (de) 2000-10-26
BR9608839A (pt) 1999-06-08
HRP960233A2 (en) 1997-08-31
EP0828703A1 (en) 1998-03-18
KR100399511B1 (ko) 2003-12-31
CZ292848B6 (cs) 2003-12-17
TW402581B (en) 2000-08-21
HU223565B1 (hu) 2004-09-28
EA000107B1 (ru) 1998-08-27
NZ308824A (en) 1998-11-25
DK0828703T3 (da) 2000-11-20
JP2839717B2 (ja) 1998-12-16
AU709273B2 (en) 1999-08-26
EA199700426A1 (ru) 1998-06-25
EP0828703B1 (en) 2000-09-20
CN1119319C (zh) 2003-08-27
KR19990021899A (ko) 1999-03-25
SK282412B6 (sk) 2002-01-07
HUP9802566A2 (hu) 1999-06-28
JPH10506642A (ja) 1998-06-30
CA2220389A1 (en) 1996-11-28
PT828703E (pt) 2001-01-31
SK156997A3 (en) 1998-09-09
CN1185146A (zh) 1998-06-17
CA2220389C (en) 2005-12-06
AR002997A1 (es) 1998-05-27
HRP960233B1 (en) 2001-08-31
DE69610422T2 (de) 2001-04-19
US5633405A (en) 1997-05-27
HUP9802566A3 (en) 2001-01-29
YU48940B (sh) 2002-12-10
ATE196463T1 (de) 2000-10-15
WO1996037457A1 (en) 1996-11-28
GR3034897T3 (en) 2001-02-28
US5698741A (en) 1997-12-16
MX9709064A (es) 1998-03-31
UA56137C2 (uk) 2003-05-15

Similar Documents

Publication Publication Date Title
YU31496A (sh) Asimetrična sinteza (-)6-hlor-4-ciklopropiletinil-4-trifluorometil-1,4-dihidro-2h-3,1-benzoksazin-2-ona
YU3696A (sh) Poboljšana sinteza ciklopropilacetilena
DK0960109T3 (da) Fremgangsmåde til fremstilling af tolterodin
DK0715618T3 (da) Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
GT199800197AA (es) Proceso para la sintesis de 1,3-dioles
DK1007092T3 (da) En fremgangsmåde til inhibering af komplementaktivering via det alternative forlöb
WO2003045443A3 (en) A system for selecting feminine hygiene products
MX9102137A (es) Inhibidores de proteasa retroviral.
NO20025004L (no) Fremgangsmåte for fremstilling av 2,5-diketopiperaziner, 2,5- diketopiperaziner, dipeptider samt anvendelse derav
WO1998051163A3 (en) Methods of producing protein hydrolysates
NO892099D0 (no) Anvendelse av 1,1,1,4,4,4-heksafluorbutan som driv- og demmegass for fremstilling av plastskumstoffer.
BR9909819A (pt) Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
PT981520E (pt) Reaccao de adicao enantiosselectiva eficaz utilizando um reagente de organozinco
LV12432A (lv) Benzooksazinonu asimetriska sinteze
MA26486A1 (fr) Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
ES1051154Y (es) Collar de presion
ATE425246T1 (de) Hydrophile zusammensetzung, die eine von vibrio proteolyticus hergestellte protease enthält
DK0787135T3 (da) Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh
BR9404367A (pt) Processo para a preparação de um polímero radial assimétrico, e, polímero radial assimétrico.
PA8469601A1 (es) Procedimiento para alquilar sulfonamidas impedidas estericamente
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
DK0825859T3 (da) Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed
ATE192432T1 (de) N-geschützte/n-substituierte beta- aminohydroxysulfonate
BRPI0416712A (pt) uso de tripeptìdeo xpp, produto alimentìcio e processo para a preparação de um produto alimentìcio
AR011636A1 (es) Procedimiento para la separacion de 2-aminometilciclopentilamina a partir de una mezcla que contiene hexametilendiamina y 2-aminometilciclopentilamina